首页 | 本学科首页   官方微博 | 高级检索  
     


In Vitro and In Vivo Evaluation of N‐{2‐[4‐(3‐Cyanopyridin‐2‐yl)piperazin‐1‐yl]ethyl}‐3‐[11C]methoxybenz­amide,a Positron Emission Tomography (PET) Radioligand for Dopamine D4 Receptors,in Rodents
Authors:Marcello Leopoldo  Svetlana V. Selivanova  Adrienne Müller  Enza Lacivita  Simon M. Ametamey
Affiliation:1. Dipartimento di Farmacia – Scienze del Farmaco, Università degli Studi di Bari ‘A. Moro', via Orabona, 4, IT‐70125 Bari;2. Center for Radiopharmaceutical Sciences of ETH, PSI and USZ, Department of Chemistry and Applied Biosciences of ETH Zurich, CH‐8093 Zurich, (phone: +41‐44‐6337463;3. fax: +41‐44‐6331367);4. fax: +41‐44‐6331367)Co‐senior authors.
Abstract:The D4 dopamine receptor belongs to the D2‐like family of dopamine receptors, and its exact regional distribution in the central nervous system is still a matter of considerable debate. The availability of a selective radioligand for the D4 receptor with suitable properties for positron emission tomography (PET) would help resolve issues of D4 receptor localization in the brain, and the presumed diurnal change of expressed protein in the eye and pineal gland. We report here on in vitro and in vivo characteristics of the high‐affinity D4 receptor‐selective ligand N‐{2‐[4‐(3‐cyanopyridin‐2‐yl)piperazin‐1‐yl]ethyl}‐3‐[11C]methoxybenzamide ([11C] 2 ) in rat. The results provide new insights on the in vitro properties that a brain PET dopamine D4 radioligand should possess in order to have improved in vivo utility in rodents.
Keywords:Positron emission tomography (PET)  G‐Protein‐coupled receptors (GPCR)  Dopamine D4 receptors  Piperazine, 1‐aryl‐  Rodent
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号